Carlsmed, Inc. reports results for the quarter ended June 30 - Earnings Summary

Carlsmed

06/08/2026 01:01

Carlsmed, Inc. CARL.OQ reported a quarterly adjusted loss of 39 cents​​ per share for the quarter ended June 30.  The mean expectation of five analysts for the quarter was for a loss of 41 cents per share. Wall Street expected results to range from -47 cents to -38 cents per share.
Revenue was $18.94 million​; analysts expected $17.95 million. 
Carlsmed, Inc.'s reported EPS for the quarter was a loss of 39 cents​.
The company reported a quarterly loss of $10.51 million.
Carlsmed, Inc. shares had risen by 29.4% this quarter and gained 8.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 2% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Carlsmed, Inc. is $18.00, about 24.7% above its last closing price of $13.56
This summary was machine generated from LSEG data August 6 at 12:01 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.41
-0.39
Beat
Mar. 31 2026 
-0.39
-0.32
Beat
Dec. 31 2025 
-0.43
-0.32
Beat
Sep. 30 2025 
-0.45
-0.40
Beat